4.6 Article

Non-coding RNAs, guardians of the p53 galaxy

Journal

SEMINARS IN CANCER BIOLOGY
Volume 75, Issue -, Pages 72-83

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2020.09.002

Keywords

Cancer; Circular RNA; Long non-coding RNA; MicroRNA; p53; mutant p53

Categories

Funding

  1. National Key R&D Pro-gram of China [2018YFA0107100]
  2. National Natural Science Foundation of China [81772588, 81972307, U19A2008, 81970153, 81773132]
  3. National Health and Medical Research Council of Australia [1147271]
  4. National Health and Medical Research Council of Australia [1147271] Funding Source: NHMRC

Ask authors/readers for more resources

This review highlights the important roles of the TP53 gene and its protein product, p53, in tumor development, discussing how ncRNAs contribute to tumorigenesis by modulating levels and activity of p53, and their roles within the p53 regulatory network.
The TP53 gene is arguably the most important tumor suppressor gene known, contributing multifaceted roles to the process of tumor development. Its protein product p53, is a crucial sequence-specific transcription factor which regulates the expression of a large network of protein-coding genes, as well as thousands of noncoding RNAs (ncRNAs), notably microRNAs and long ncRNAs (lncRNAs). Through a variety of direct and indirect mechanisms, ncRNAs in turn modulate p53 levels and activity. Here the numbers of studies are steadily building which link the contributions of dysregulated ncRNAs to tumorigenesis via their participation throughout the p53 regulatory network. In this review, we will examine how the principal forms of ncRNAs, namely microRNAs, lncRNAs and circular RNAs (circRNAs) function as either effectors or regulators amongst the diversity of p53 ' s cellular responses. We first discuss the more recently discovered connections between miRNAs and p53 signaling before focusing on the remarkable diversity of crosstalk evident between lncRNAs and p53, and subsequently, developing reports linking circRNAs to p53. Highlighted throughout the review are the mechanistic impacts of dysregulated ncRNAs on p53 functions as well as the possible prognostic implications of these interactions. We also describe the emerging connections between ncRNAs and the often-perplexing functions of mutant p53. Finally, in the context of p53 therapeutic approaches, we describe some of the challenges in ncRNA research and their potential for translation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available